Mintz has advised Axoft. Axoft, a neurotechnology company specializing in soft, implantable brain-computer interfaces (iBCIs), has secured $55 million in Series A funding. This investment is…
Axoft Raises $55 Million Series A to Advance Global Clinical Trials for Soft Brain-Computer Interfaces

























